Is it good or bad to find a BRAF mutation?

J Clin Oncol. 2011 Apr 1;29(10):1229-30. doi: 10.1200/JCO.2010.34.0497. Epub 2011 Feb 22.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Age Factors
  • Antineoplastic Agents / therapeutic use
  • DNA Mutational Analysis
  • Disease-Free Survival
  • Genetic Predisposition to Disease
  • Humans
  • Melanoma / drug therapy
  • Melanoma / enzymology
  • Melanoma / genetics*
  • Melanoma / mortality
  • Melanoma / pathology
  • Mutation*
  • Phenotype
  • Protein Kinase Inhibitors / therapeutic use
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors
  • Proto-Oncogene Proteins B-raf / genetics*
  • Proto-Oncogene Proteins B-raf / metabolism
  • Risk Assessment
  • Risk Factors
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / enzymology
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / mortality
  • Skin Neoplasms / pathology
  • Time Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf